Filing Details
- Accession Number:
- 0001144204-18-039048
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-07-19 21:01:02
- Reporting Period:
- 2018-07-17
- Accepted Time:
- 2018-07-19 21:01:02
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1069899 | Phibro Animal Health Corp | PAHC | Pharmaceutical Preparations (2834) | 131840497 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1241560 | Jack Bendheim | 300 Frank W. Burr Blvd., Ste 21 Teaneck NJ 07666 | President And Ceo | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Class A Common Stock | Acquisiton | 2018-07-17 | 17,470 | $0.00 | 47,470 | No | 4 | C | Indirect | See |
Class A Common Stock | Disposition | 2018-07-17 | 9,470 | $48.20 | 38,000 | No | 4 | S | Indirect | See |
Class A Common Stock | Disposition | 2018-07-18 | 4,000 | $47.95 | 34,000 | No | 4 | S | Indirect | See |
Class A Common Stock | Disposition | 2018-07-19 | 4,000 | $47.22 | 30,000 | No | 4 | S | Indirect | See |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | C | Indirect | See |
No | 4 | S | Indirect | See |
No | 4 | S | Indirect | See |
No | 4 | S | Indirect | See |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Class A Common Stock | Class B Common Stock | Disposition | 2018-07-17 | 17,470 | $0.00 | 17,470 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
20,318,034 | No | 4 | C | Direct |
Footnotes
- Class B Common Stock is convertible into Class A Common Stock at any time on a one-for-one basis and has no expiration date.
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2017.
- The securities are held by BFI Co., LLC. Mr. Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFICo., LLC and may be deemed to have shared voting and investment power over the securities held by BFI Co., LLC. Mr. Bendheim disclaims beneficialownership of these securities except to the extent of his pecuniary interest therein.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.95 to $48.50, inclusive.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.75 to $48.40, inclusive.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.10 to $47.40, inclusive.